Waltham, Massachusetts — August 22, 2025 — Leads & Copy — Repligen Corporation (NASDAQ:RGEN) will participate in three upcoming investor conferences. President and CEO Olivier Loeillot will participate in an analyst-led discussion at the Wells Fargo Healthcare Conference in Boston on September 4 at 8:00 a.m. ET. CFO Jason Garland will participate in 1×1 meetings at the Deutsche Bank Healthcare Summit in New York on September 10. Loeillot will also participate in an analyst-led discussion at the Bank of America Global Healthcare Conference in London on September 25 at 6:35 a.m. ET/11:35 a.m. British Summer Time.
A live webcast of the conference presentations will be accessible through Repligen’s Investor Relations website, and will be available for replay for a limited time.
Repligen Corporation develops and commercializes bioprocessing technologies and systems for manufacturing biological drugs. The company’s focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Repligen’s corporate headquarters are located in Waltham, Massachusetts, and the majority of its manufacturing sites are in the U.S., with additional key sites in Estonia, France, Germany, Ireland, the Netherlands and Sweden.
Contact: Jacob Johnson, VP, Investor Relations, 781-419-0204, investors@repligen.com
Source: Repligen Corporation
